VEEV - Veeva Systems Inc.
Automates data reconciliation, saving clinical teams significant cost, time, and effort PLEASANTON, Calif., Oct. 6, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva DQS (Data Quality System) has aggregated and cleaned data for more than 1 million subjects in more than 1,000 studies to accelerate the delivery of analysis-ready data and trial insights.
Rockland Trust Co. lowered its position in Veeva Systems Inc. (NYSE: VEEV) by 2.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 169,806 shares of the technology company's stock after selling 3,954 shares during the quarter. Veeva Systems
VEEV's OpenData deal with Servier across 80+ countries strengthens its Data Cloud role as life sciences firms scale AI and advanced analytics.
Veeva Systems (VEEV) reached $273.25 at the closing of the latest trading day, reflecting a -3.08% change compared to its last close.
Veeva Systems (VEEV) closed the most recent trading day at $281.93, moving 1.23% from the previous trading session.
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Establishing an AI-ready data foundation in more than 80 countries PLEASANTON, Calif., Sept. 30, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Servier is standardizing customer reference data across more than 80 countries with Veeva OpenData.
Shares of Veeva Systems Inc. (NYSE: VEEV - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the twenty-eight research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and nineteen have given a buy rating
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Veeva Systems (VEEV) closed the most recent trading day at $280.68, moving +2.12% from the previous trading session.
VEEV's AI-powered Study Builder Agent automates clinical study setup, cutting manual work while strengthening its connected Clinical Data ecosystem.
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?
The AI trade has trained investors to look for the next Nvidia Corp (NASDAQ:NVDA), the next chip winner or the next company selling picks and shovels to data centers. But Allen Bond, Managing Director and Portfolio Manager at Jensen Investment Management, sees opportunity somewhere less glamorous: software and business-services companies whose competitive advantages are easy to overlook in an AI-obsessed market.
Standards-first agent delivers faster and more consistent EDC and DQS builds PLEASANTON, Calif., Sept. 24, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Study Builder Agent, a new AI solution that configures Veeva EDC and Veeva DQS (Data Quality System) directly from a study protocol.
VEEV launches Falcon Router to automate biopharma case routing, deepening AI integration across regulated life sciences workflows.
With 190 live customers and 14 top 20 biopharma commitments, Vault CRM is the fastest path to AI PLEASANTON, Calif., Sept. 23, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a new top 20 biopharma commitment, adding to recent selections by Amgen, Biogen, Eli Lilly and Company, and Regeneron.
VEEV expands its decade-long Amgen partnership with a global Vault CRM rollout, reinforcing enterprise adoption and commercial subscription growth.
PLEASANTON, Calif., Sept. 21, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Falcon Router, an industry-specific agent to identify and route potential safety adverse event reports, product quality complaints, and medical inquiries to the correct teams with speed and consistency.
Nykredit A S acquired a new position in shares of Veeva Systems Inc. (NYSE: VEEV) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 61,859 shares of the technology company's stock, valued at approximately $10,978,000. A number of other institutional investors also recently added
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.